Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diosmin as Adjuvant Therapy in Non-bleeding Peptic Ulcer
NCT05670457Phase 3Unknown
- Sponsor
- Tanta University
- Start
- Jun 2022
- Primary completion
- Jun 2024
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of diosmin in peptic ulcer disease (PUD), sponsored by Tanta University. Status: unknown.
02
Drugs
diosmin
03
Conditions
peptic ulcer disease (PUD)
Beyond the preview
Go deeper on NCT05670457.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05670457.